Picture of Atrion logo

ATRI Atrion Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Momentum

Relative Strength (%)
1m-14.33%
3m-35.16%
6m-45.91%
1yr-55.11%
Volume Change (%)
10d/3m+45.6%
Price vs... (%)
52w High-56.92%
50d MA-17.16%
200d MA-41.7%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital9.91%
Return on Equity8.76%
Operating Margin14.66%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Atrion EPS forecast chart

Profile Summary

Atrion Corporation (Atrion) is engaged in the development and manufacture of products for medical applications. The Company's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. It has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. Atrion's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. Atrion also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
December 30th, 1996
Public Since
March 18th, 1980
No. of Shareholders
14,739
No. of Employees
722
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
1,759,836

ATRI Share Price Performance

Upcoming Events for ATRI

Dividend For ATRI.OQ - 2.2000 USD

Q4 2023 Atrion Corp Earnings Release

Q1 2024 Atrion Corp Earnings Release

Atrion Corp Annual Shareholders Meeting

Similar to ATRI

Picture of 10X Genomics logo

10X Genomics

us flag iconNASDAQ Global Select Market

Picture of Accuray logo

Accuray

us flag iconNASDAQ Global Select Market

Picture of Akoya Biosciences logo

Akoya Biosciences

us flag iconNASDAQ Global Select Market

Picture of Align Technology logo

Align Technology

us flag iconNASDAQ Global Select Market

Picture of Alphatec Holdings logo

Alphatec Holdings

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email